Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.

• 資料種別: 博士論文
• タイトル: Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.
• 著者・編者: Sasaki, Shoh; Takeda, Maiko; Hirose, Takanori; Fujii, Tomomi; Itami, Hiroe; Uchiyama, Tomoko; Morita, Kohei; Matsuda, Ryosuke; Yamada, Shuichi; Nakagawa, Ichiro; Ohbayashi, Chiho
• 著者標目: Sasaki, Shoh; Takeda, Maiko; Hirose, Takanori; Fujii, Tomomi; Itami, Hiroe; Uchiyama, Tomoko; Morita, Kohei; Matsuda, Ryosuke; Yamada, Shuichi; Nakagawa, Ichiro; Ohbayashi, Chiho
• 出版事項: Oxford University Press
• 出版年月日等: 2022-02
• 出版年（W3CDTF）: 2022-02
• 並列タイトル等: CNS WHO Grade 2 および Grade 3 髄膜腫における、MTAP免疫組織化学とFISH解析によるCDKN2Aコピー数および臨床病理学的特徴との相関性
• タイトル（掲載誌）: Journal of neuropathology and experimental neurology
• 巻号年月日等（掲載誌）: 81 2
• 掲載巻: 81
• 掲載号: 2
• 掲載ページ: 117-126
• ISSN（掲載誌）: ISSN : 0022-3069
• 授与機関名: 奈良県立医科大学
• 授与年月日: 2022-03-15
• 報告番号: 甲第840号
• 学位: 博士（医学）
• 本文の言語コード: eng
• 件名標目: CDKN2A homozygous deletion; Fluorescence in situ hybridization (FISH); Meningioma; MTAP; Spatial and temporal heterogeneity
• 対象利用者: 一般
• 一般注記: type:Thesis; CDKN2A homozygous deletion has occasionally been reported in atypical and anaplastic meningiomas and is considered as one of the genetic alterations commonly involved in their recurrence and malignant progression. Methylthioadenosine phosphorylase (MTAP) immunohistochemistry is a promising surrogate marker for CDKN2A homozygous deletion in different cancers but has not been examined in meningiomas. We performed CDKN2A FISH and MTAP immunohistochemistry on specimens from 30 patients with CNS WHO grade 2 (n = 27) and 3 (n = 3) meningiomas, including specimens from primary and recurrent tumors and then determined whether MTAP immunohistochemistry correlated with CDKN2A homozygous deletion and clinicopathological features. CDKN2A homozygous deletion was detected in 12% (3/26) of CNS WHO grade 2 and 67% (2/3) of CNS WHO grade 3 meningiomas; 3 cases exhibited temporal and/or spatial heterogeneity. MTAP loss was in excellent concordance with CDKN2A homozygous deletion (sensitivity; 100%, specificity; 100%). MTAP loss/CDKN2A homozygous deletion correlated with cellular proliferation (mitotic rate; p = 0.001, Ki-67 labeling index; p = 0.03) and poor prognosis (overall survival; p = 0.01, progression free survival; p < 0.001). Thus, MTAP immunostaining can be a surrogate marker for CDKN2A homozygous deletion in meningiomas, and MTAP loss/CDKN2A homozygous deletion may be an important prognostic factor for meningiomas.; 博士（医学）・甲第840号・令和4年3月15日; © 2021 American Association of Neuropathologists, Inc. All rights reserved.; This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of neuropathology and experimental neurology following peer review. The version of record "Vol.81 issue 2 p.117-126 (2022 Jan 29)" is available online at: https://doi.org/10.1093/jnen/nlab127.; identifier:Journal of neuropathology and experimental neurology Vol.81 No.2 p.117-126 (2022 Feb); identifier:00223069; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/4023; identifier:Journal of neuropathology and experimental neurology, 81(2): 117-126
• 一次資料へのリンクURL: comment：fulltext; http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4023/1/01%e7%94%b2840%e6%9c%ac%e6%96%87%e3%81%ae%e8%a6%81%e6%97%a8.pdf; http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4023/2/02%e7%94%b2840%e5%af%a9%e6%9f%bb%e8%a6%81%e6%97%a8.pdf; http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4023/8/03%e7%94%b2840%e6%9c%ac%e6%96%87.pdf
• オンライン閲覧公開範囲: インターネット公開
• 関連情報（DOI）: 10.1093/jnen/nlab127
• 掲載誌（NCID）: AA00703323; https://ci.nii.ac.jp/ncid/AA00703323
• 連携機関・データベース: 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• 提供元機関・データベース: 奈良県立医科大学 : 奈良県立医科大学機関リポジトリ GINMU